ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.

Insulet, an Acton-based medical device firm specializing in diabetes treatment, has launched commercialization efforts for its tubeless insulin device in the United Kingdom. The tubeless insulin ...

Many people with diabetes prefer an insulin pump to insulin injections. Here's how to know if it's right for you.

The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a ...

Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a U.S. Food and Drug Administration announcement on Wednesday ...

CHICAGO — Insulin pumps are used by tens of thousands of teenagers worldwide with Type 1 diabetes, but they can be risky and have been linked to injuries and even deaths, a review by federal ...

Please provide your email address to receive an email when new articles are posted on . Weiner: Is insulin pump therapy recommended for people with type 2 diabetes who require basal-bolus therapy?

A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...

A leading diabetes expert is urging Australia to make access to a game-changing medical device easier and cheaper for those ...

AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) ...